SMAD4 and neoplasm: Interestingly, in ex vivo cultures derived from PDX, the cell subpopulation displaying heterozygous SMAD4 loss by deletion or reduced expression outcompeted cells with wildtype SMAD4 genotype from the parental tumor, suggesting a survival advantage of Smad4-deficient cells [54].